June 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

4 mL syringe (NDC 00409-9631-04) 2 mL Carpuject syringe (NDC 00409-1275-32) - discontinued 10 mL syringe (NDC 00409-6102-10) Furosemide Injection, 10 mg/mL, American Regent 2 mL vial (NDC 00517-5702-25) 4 mL vial (NDC 00517-5704-25) 10 mL vial (NDC 00517-5710-25) Furosemide Injection, 10 mg/mL, APP 1 2 mL vial (NDC 63323-0280-02) 4 mL vial (NDC 63323-0280-04) Reason for the Shortage • APP has furosemide injection on shortage due to increased demand for the product. • American Regent had temporarily suspended manufacture of most drug products including furosemide in April, 2011. • American Regent resumed manufacturing in Shirley, New York in early-May, 2011. • Hospira has furosemide on shortage due to manufacturing delays. • Wockhardt has discontinued all furosemide injection presentations. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=636 Source website: www.ashp.org Fluorouracil Injection May 30, 2012 Products Affected - Description Fluorouracil injection 50 mg/mL, Mylan Institutional 100 mL vial (NDC 10139-0063-01) Reason for the Shortage • APP stated fluorouracil was on allocation to prevent excessive purchases. • Teva stated their fluorouracil shortage was due to manufacturing delays. • Mylan Institutional states the reason for the shortage is that demand exceeds supply due to market conditions. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=798 Source website: www.ashp.org Desmopressin Rhinal Tubes May 30, 2012 Products Affected - Description Desmopressin rhinal tubes, Ferring 0.1 mg/mL, 2.5 mL rhinal tubes (NDC 55566-5020-01) DDAVP rhinal tubes, Sanofi-Aventis 0.1 mg/mL, 2.5 mL rhinal tubes (NDC 55566-5020-01) Reason for the Shortage • Ferring has desmopressin rhinal tubes on shortage due to manufacturing delays. • Sanofi-Aventis cannot provide a reason for the shortage of DDAVP rhinal tubes. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=914 Source website: www.ashp.org 108
Ampicillin Sulbactam May 30, 2012 Products Affected - Description Ampicillin Sulbactam powder for injection, Hospira 1.5 gram vial, 10 count (NDC 00409-2988-01) 1.5 gram ADD-Vantage vial, 10 count (NDC 00409-2689-01) 3 gram vial, 10 count (NDC 00409-2998-03) 3 gram ADD-Vantage vial, 10 count (NDC 00409-2987-03) 3 gram Novaplus vial, 10 count (NDC 00409-2987-13) 15 gram bulk vial, 1 count (NDC 00409-2687-15) Unasyn powder for injection, Pfizer 1.5 gram Add-Vantage vial, 10 count (NDC 00049-0031-83) - discontinued 1.5 gram bottles, 10 count (NDC 00049-0022-83) - discontinued 3 gram ADD-Vantage vial, 10 count (NDC 00049-0032-83) - discontinued 3 gram bottle, 10 count (NDC 00049-0023-83) - discontinued 15 gram bulk vial, 1 count (NDC 00049-0024-28) Ampicillin Sulbactam powder for injection, Sagent 1.5 gram vial, 10 count (NDC 25021-0142-20) 3 gram vial, 10 count (NDC 25021-0143-30) 15 gram bulk vial, 1 count (NDC 25021-0144-99) Ampicillin Sulbactam powder for injection, West-Ward 1.5 gram vial, 10 count (NDC 10019-0631-01) – NDC discontinued 3 gram vial, 10 count (NDC 10019-0630-02) – NDC discontinued 15 gram bulk vial, 1 count (NDC 10019-0632-03) – NDC discontinued 1.5 gram NOVAPLUS vial, 10 count (NDC 10019-0636-01) - NDC discontinued 3 gram NOVAPLUS vial, 10 count (NDC 10019-0637-02) - NDC discontinued 15 gram NOVAPLUS bulk vial, 1 count (NDC 10019-0638-03) - discontinued 1.5 gram vial, 10 count (NDC 00641-6116-10) 1.5 gram NOVAPLUS vial, 10 count (NDC 00641-6119-10) 3 gram vial, 10 count (NDC 00641-6117-10) 3 gram NOVAPLUS vial, 10 count (NDC 00641-6120-10) 15 gram bulk vial, 1 count (NDC 00641-6118-01) Reason for the Shortage • Hospira states that ampicillin sulbactam vials are on back order due to raw material shortages. • Sagent cannot provide a reason for the shortage. • Sandoz states the shortage was due to increased demand for the products. • Pfizer discontinued Unasyn 3 gram 10 count bottles in late, 2011. Pfizer discontinued all Unasyn Add-Vantage vials and bottles in early 2012. • West-Ward acquired several Baxter products in early 2011. The company discontinued ampicillin sulbactam 15 gram NOVAPLUS vials in May, 2012. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=805 Source website: www.ashp.org BCG Vaccine Live Intravesical May 31, 2012 Products Affected - Description 109
Page 1 and 2:
June 2012 Drug Information Update
Page 3 and 4:
First-Time Generics GENERIC DRUG NA
Page 5 and 6:
ANTI-DIARRHEALS OPIUM TINCTURE DISP
Page 7 and 8:
indicated for the treatment of HIV-
Page 9 and 10:
Source website: http://www.fda.gov/
Page 11 and 12:
Testosterone Chases Viagra in Libid
Page 13 and 14:
Analytical Trend Troubles Scientist
Page 15 and 16:
Testosterone supplements may help m
Page 17 and 18:
voted 19-3 to endorse the drug's us
Page 19 and 20:
New Drug Trial Seeks to Stop Alzhei
Page 21 and 22:
translates into a 38 percent reduct
Page 23 and 24:
atypical fractures of the thigh bon
Page 25 and 26:
contain Sibutramine, an appetite su
Page 27 and 28:
2 fl oz UPC 011673257424. Recall #
Page 29 and 30:
NDC 5816082101 (single dose vial);
Page 31 and 32:
Manufacturer: Catalent Argentina S.
Page 33 and 34:
• Fera cannot provide a reason fo
Page 35 and 36:
• Akorn states the reason for the
Page 37 and 38:
Reason for the Shortage • Teva st
Page 39 and 40:
15 gram Novaplus bulk vial, 1 count
Page 41 and 42:
Milrinone Injection May 9, 2012 Pro
Page 43 and 44:
• Ranbaxy has all discontinued me
Page 45 and 46:
Doxorubicin Liposomal Injection May
Page 47 and 48:
1 mg/mL, 2 mL vial, 25 count (NDC 6
Page 49 and 50:
• APP has leucovorin on shortage
Page 51 and 52:
• West-Ward acquired Baxter’s o
Page 53 and 54:
• Ethinyl estradiol/norethindrone
Page 55 and 56:
Potassium chloride for injection, H
Page 57 and 58: Labetalol tablets, Sandoz 100 mg, 1
Page 59 and 60: the gray market. • Ferring has No
Page 61 and 62: Source website: www.ashp.org Loraze
Page 63 and 64: Fentanyl Injection 50 mcg/mL, Hospi
Page 65 and 66: Bupivacaine Injection May 17, 2012
Page 67 and 68: Article link: http://www.ashp.org/D
Page 69 and 70: Heparin Sodium Injection May 18, 20
Page 71 and 72: o Heparin sodium 10 unit/mL, 5 mL l
Page 73 and 74: Article link: http://www.ashp.org/D
Page 75 and 76: • Amphastar and Baxter have disco
Page 77 and 78: Fludarabine Injection May 21, 2012
Page 79 and 80: TheraCys Intravesical Injection, Sa
Page 81 and 82: Nystatin Oral Suspension May 22, 20
Page 83 and 84: discontinued the 1 mg/mL 4 mL vials
Page 85 and 86: 10 gram vial (NDC 63323-0314-61) Va
Page 87 and 88: 10 mg/mL, 10 mL vial (NDC 63323-020
Page 89 and 90: Papaverine injection Reason for the
Page 91 and 92: • Mylan Institutional (formerly B
Page 93 and 94: 20 mg, 100 count (NDC 00781-1695-01
Page 95 and 96: 4 mL vial (NDC 00641-6008-10) 10 mL
Page 97 and 98: 20 mL vials (NDC 00069-1340-02) Ond
Page 99 and 100: ecently changed old Baxter to new W
Page 101 and 102: 1 mg/mL, 2 mL vial, 25 count (new N
Page 103 and 104: 250 mg, 100 count unit dose (NDC 00
Page 105 and 106: Granisetron Hydrochloride Injection
Page 107: 15 mg/mL, 10 mL vial (NDC 63323-048
show all

June 2012 Drug Information Update - Pharmacy Benefits ...

Create successful ePaper yourself

Delete template?

Save as template?